Abingdon Health Plc reported revenue results for the six months ended December 31, 2023. For the period, the company reported revenues more than doubled (+118%) to £2.4 million (first of 2022/3 £1.1 million). The growth has been driven by the company's contract service customer base across lateral flow research & development, technical transfer, manufacturing, analytical and regulatory services.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.75 GBX | -2.50% | 0.00% | -11.36% |
May. 07 | Abingdon Health buys IVDeology Holdings | AN |
May. 07 | Abingdon Health Plc acquired Ivdeology Holdings Ltd for £0.7 million. | CI |
1st Jan change | Capi. | |
---|---|---|
-11.36% | 37.57M | |
-1.29% | 12.64B | |
-0.47% | 8.46B | |
+22.61% | 5.27B | |
-2.03% | 4.49B | |
-53.56% | 3.11B | |
+19.30% | 2.87B | |
+33.07% | 2.31B | |
-8.42% | 2.23B | |
-3.55% | 1.89B |
- Stock Market
- Equities
- ABDX Stock
- News Abingdon Health Plc
- Abingdon Health Plc Reports Revenue Results for the Six Months Ended December 31, 2023